Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors

This study has been withdrawn prior to recruitment.

Study NCT00227773 Information provided by National Cancer Institute (NCI)

First Received: September 26, 2005 Last Updated: October 24, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been withdrawn prior to recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given